{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T06:31:44Z","timestamp":1675578704410},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>A recent community-based disease management (CBDM) pilot study reported a 20.5% prevalence of hypertension and a 0.5 and 3.6% prevalence of stroke and coronary heart disease (CHD), respectively, in an elderly population (mean age 65\u2009years) in the Xin Jiang autonomous region of China. The CBDM was initiated in 2013 as an essential public health service; however, the potential long-term impact of CBDM on cardiovascular (CV: CHD and stroke) events is unknown. The objective of the study was to understand the long-term impact of CBDM interventions on CV risk factors using disease-model simulation based on a single-arm experimental study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A discrete event simulation was developed to evaluate the impact of CBDM on the long-term CV risk among patients with hypertension, in China\u2019s Xin Jiang autonomous region. The model generated pairs of identical patients; one receives CBDM and one does not (control group). Their clinical courses were simulated based on time to CV events (CHD and strokes), which are estimated using published risk equations. The impact of CBDM was incorporated as improvement in systolic blood pressure (SBP) based on observations from the CBDM study. The simulation estimated the number of CV events over patients\u2019 lifetimes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>During a 2-year follow up, the CBDM led to an average reduction of 8.73\u2009mmHg in SBP from baseline, and a 42% reduction in smoking. The discrete event simulation showed that, in the control group, the model estimated incidence rates of 276, 1789, and 616 per 100,000 individuals for lifetime CHD, stroke, and CV-related death, respectively. The impact of CBDM on SBP translated into reductions of 8, 28, and 23% in CHD, stroke, and CV-related deaths, respectively. Taking into account CBDM\u2019s reduction of both SBP and smoking, deaths from CHD, stroke, and CV-related deaths were reduced by 12, 30, and 26%, respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The implementation of CBDM in China\u2019s Xinjiang autonomous region is expected to significantly reduce incidences of CHD, strokes, and CV-related deaths.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09157-8","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T16:04:37Z","timestamp":1593446677000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China"],"prefix":"10.1186","volume":"20","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Minzhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Minghui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Xinmiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Laixin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Bei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Weihai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan","family":"Yumei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thitima","family":"Kongnakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naranjargal","family":"Dashdorj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"9157_CR1","unstructured":"Chen W, Gao R, Lisheng L, et al. Report on cardiovascular disease in China 2015 (in Chinese). Chin Circ J. 2016;31(6)."},{"issue":"7","key":"9157_CR2","first-page":"552","volume":"27","author":"W Wang","year":"2014","unstructured":"Wang W, Hu SS, Kong LZ, Gao RL, Zhu ML, Wang WY, Wu ZS, Chen WW, Yang JG, Ma LY, et al. Summary of report on cardiovascular diseases in China, 2012. Biomed Environ Sci. 2014;27(7):552\u20138.","journal-title":"Biomed Environ Sci"},{"key":"9157_CR3","doi-asserted-by":"crossref","unstructured":"Zhang X, Feldmam R, Wu Z, Zhang Y, Yu X, Liu L. Lb03.09: Therapeutic Inertia Is a Major Determinant of BP Control Rates in China. A Hypertension Attitude Perspectives and Needs (Happen) Study Report. J Hypertens. 2015;33 Suppl 1:e128.","DOI":"10.1097\/01.hjh.0000467699.90241.64"},{"issue":"6","key":"9157_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","volume":"15","author":"JJ Caro","year":"2012","unstructured":"Caro JJ, Briggs AH, Siebert U, Kuntz KM, Force I-SMGRPT. Modeling good research practices--overview: a report of the ISPOR-SMDM modeling good research practices task Force--1. Value Health. 2012;15(6):796\u2013803.","journal-title":"Value Health"},{"issue":"6","key":"9157_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jval.2012.04.013","volume":"15","author":"J Karnon","year":"2012","unstructured":"Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Moller J, Force I-SMGRPT. Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task Force--4. Value Health. 2012;15(6):821\u20137.","journal-title":"Value Health"},{"key":"9157_CR6","doi-asserted-by":"publisher","DOI":"10.1201\/b19421","volume-title":"Discrete event simulation for health technology assessment","author":"JJ Caro","year":"2015","unstructured":"Caro JJ, M\u00f6ller J, Stahl J, Karnon J. Discrete event simulation for health technology assessment. New York, NY: Chapman and Hall\/CRC; 2015."},{"issue":"21","key":"9157_CR7","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","volume":"291","author":"J Liu","year":"2004","unstructured":"Liu J, Hong Y, D\u2019Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA. 2004;291(21):2591\u20139.","journal-title":"JAMA."},{"issue":"21","key":"9157_CR8","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1161\/CIRCULATIONAHA.105.607499","volume":"114","author":"Y Wu","year":"2006","unstructured":"Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Li Y, Rao X, Zhou B, Detrano R, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006;114(21):2217\u201325.","journal-title":"Circulation."},{"issue":"3","key":"9157_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCOUTCOMES.109.910711","volume":"3","author":"A Moran","year":"2010","unstructured":"Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, et al. Future cardiovascular disease in China: markov model and risk factor scenario projections from the coronary heart disease policy model-China. Circ Cardiovasc Qual Outcomes. 2010;3(3):243\u201352.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"9157_CR10","unstructured":"WHO - Life tables by country: China 2013 [http:\/\/apps.who.int\/gho\/data\/view.main.60340]."},{"key":"9157_CR11","unstructured":"China Demographics Profile 2014 [http:\/\/www.indexmundi.com\/china\/demographics_profile.html]."},{"key":"9157_CR12","unstructured":"Universal health coverage [http:\/\/www.who.int\/universal_health_coverage\/en\/ (Assessed on 28 August 2019)]."},{"key":"9157_CR13","unstructured":"The World Health Report [http:\/\/www.who.int\/whr\/2008\/08_contents_en.pdf]."},{"issue":"9","key":"9157_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11606-009-1051-4","volume":"24","author":"CW Cene","year":"2009","unstructured":"Cene CW, Roter D, Carson KA, Miller ER 3rd, Cooper LA. The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med. 2009;24(9):1057\u201364.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"9157_CR15","doi-asserted-by":"publisher","first-page":"e46309","DOI":"10.1371\/journal.pone.0046309","volume":"7","author":"MC Wong","year":"2012","unstructured":"Wong MC, Wang HH, Wong SY, Wei X, Yang N, Zhang Z, Li H, Gao Y, Li DK, Tang J, et al. Performance comparison among the major healthcare financing systems in six cities of the Pearl River Delta region, mainland China. PLoS One. 2012;7(9):e46309.","journal-title":"PLoS One"},{"key":"9157_CR16","doi-asserted-by":"crossref","unstructured":"Ma YT, Huang Y, Liu F, Yang Y-N, Li X-M, Sun M-H, Juan. General Cardiology: Hypertension, Prevention and Lipids Epidemiological Survey of Hypertension in General Adult Population of Different Nationalities in Xinjiang. J Am Coll Cardiol. 2011;57(14).","DOI":"10.1016\/S0735-1097(11)60589-5"},{"key":"9157_CR17","unstructured":"2016 Chinese guideline for the management of dyslipidemia in adults [https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27903370]."},{"issue":"02","key":"9157_CR18","first-page":"85","volume":"10","author":"YYNYTMWWJWLLJ Yuan","year":"2016","unstructured":"Yuan YYNYTMWWJWLLJ. Summary of \"2015 China adult tobacco survey\". Chin J Health Manag. 2016;10(02):85\u20137.","journal-title":"Chin J Health Manag"},{"issue":"7","key":"9157_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4103\/0366-6999.202742","volume":"130","author":"GX Li","year":"2017","unstructured":"Li GX, Zhou B, Qi GX, Zhang B, Jiang DM, Wu GM, Ma B, Zhang P, Zhao QR, Li J, et al. Current trends for ST-segment elevation myocardial infarction during the past 5 years in rural areas of China's Liaoning Province: a multicenter study. Chin Med J. 2017;130(7):757\u201366.","journal-title":"Chin Med J"},{"issue":"39","key":"9157_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001551","volume":"94","author":"L Zheng","year":"2015","unstructured":"Zheng L, Li J, Sun Z, Zhang X, Hu D, Sun Y. Relationship of blood pressure with mortality and cardiovascular events among hypertensive patients aged >\/= 60 years in rural areas of China: a strobe-compliant study. Medicine (Baltimore). 2015;94(39):e1551.","journal-title":"Medicine (Baltimore)"},{"key":"9157_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12913-016-1420-8","volume":"16","author":"W Stevens","year":"2016","unstructured":"Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, Lakdawalla DN. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016;16:175.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09157-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09157-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09157-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T23:26:35Z","timestamp":1624922795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09157-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9157"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09157-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"12 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committees of the Peking University, School of Public Health, and the study was conducted in accordance with the International Council on Harmonization (ICH, E6) guidelines and Declaration of Helsinki and its subsequent revisions. The data was collected by the Xinjiang CDC and the patient consents were received written before the survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YL is a faculty member at Peking University. CM was a graduate student at Peking University. MM, HX, ZW1 and ZW2 are employees of Health and Family Planning Commission of Xinjiang Uygur Autonomous Region, Urumqi, China. LL and GY are employees of Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Urumqi, China. YX, SP and TK are salaried employees of Evidera, and are not allowed to accept remuneration from any clients for their services. Evidera received funding from Novartis to conduct the study and develop this manuscript. ND is the CEO of Onom foundation, Mongolia. TH, DH, and WB are employees of Novartis Group. Authors have no other competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1034"}}